Berger’s Disease (IgA Nephropathy)
Berger’s disease, clinically referred to as IgA nephropathy, is a specific type of kidney (renal) disease characterized by an antibody (immunoglobulin IgA) build-up in the kidneys. Too much of this antibody reduces the kidneys’ ability to filter wastes in the blood and can cause kidney damage (irreversible scarring) over time. Symptoms include repeated episodes of cola- or tea-colored urine (or blood in the urine), back pain on the sides and below the ribs, swelling in the hands and feet, and high blood pressure. It is estimated that 20 to 40% of adults that have Berger’s Disease for at least 10 to 20 years develop end-stage kidney disease which requires dialysis or a possible kidney transplant.
Related Indications
Schedule a Consultation
Research
Hyperbaric oxygen treatment in thromboangiitis obliterans: a retrospective clinical audit.
Abstract: Wounds refractory to standard treatment in patients with thromboangiitis obliterans (TAO, Buerger's disease) are associated with amputation, other morbidity and mortality. The purpose of this study was to investigate the effect of hyperbaric oxygen treatment...
Cannabis arteritis.
Abstract: Cannabis is the most consumed psychoactive substance by young people. Chronic use of cannabis can lead to cannabis arteritis, which is a very rare peripheral vascular disease similar to Buerger's disease. It is affecting young adults, especially men,...
Hyperbaric Oxygen Therapy in the Treatment of Fontaine Stage IV Thromboangiitis Obliterans.
Abstract: Ischemic wounds unresponsive to standard treatment in thromboangiitis obliterans are associated with amputation, morbidity, and mortality. In this study, hyperbaric oxygen therapy was added to standard treatment of 36 patients with thromboangiitis obliterans...